medical affairs responsibilities

8.20.2014 Medical Affairs

What’s In A Name? How the Functional Title Encompasses the MSL Role

By Ryan McGuire, Head of Research The MSL role should be an easy to define. But if this is truly the case, why does the pharmaceutical industry use so many different titles used to describe the function? Besides medical science liaisons, there are...
 

8.6.2014 Medical Affairs

Pharmaceutical Call Center Management: Evolve to Respond to Better Informed Customers

By David Richardson, Director of Research Let’s face it, Google makes us smarter.  Well…not really.  But it certainly gives us a window into all kinds of information that used to be held only by professionals.  The healthcare industry has...
 

7.11.2014 Medical Affairs

Strategic Medical Publications Management: Selecting the Best-Fit Scientific Journals for Manuscript Submissions

By Sarah Ray, Research Analyst Medical publications help companies to communicate clinical trial findings, provide internal marketing support and educate the scientific community. To optimize strategic medical publications management, dedicated...
 

6.6.2014 KOL Management

KOL Management for Small Pharma Leans Heavily on Existing Networks Within Companies

By Jacob Presson, Senior Research Analyst When it comes to managing and nurturing thought leader relationships and specifically the process of identifying key opinion leaders, companies have several options. Many choose to outsource the identification...
 

4.8.2014 Medical Affairs

The Demand for and Implementation of Medical Publications Transparency

By Christie Shilling, Research Analyst I play video games often in my free time and hold a particular love for the Portal series.  At the end of the first game, there is a cute song that contains the line, “We do what we must because we can.” ...
 

4.2.2014 Medical Affairs

Making the Most of Scientific Advisory Boards with Clear Objectives

By Jacob Presson, Research Analyst When bringing together a group of active clinicians and specialists for a scientific advisory board, companies should make sure to maximize the effectiveness of the resources seated around the table.  Each person...
 

1.15.2014 Medical Affairs

Medical Affairs Embracing a Patient-Centric 2014

By Nicole May, Research Analyst As pharma moves into 2014, new technologies will allow medical affairs teams to shape their strategies to be increasingly and innovatively patient-centric.  Although a case could be made to stop using the term, whatever...
 

12.23.2013 Medical Affairs

Recent Update to ICMJE Guidelines Emphasizes Author Accountability

By Sarah Ray, Research Analyst Medical publications represent a unique forum in which the medical and commercial objectives of pharmaceutical companies may, at times, overlap.  One of the primary roles of medical publications is to describe clinical...
 

10.3.2013 KOL Management

Discussion Leader and Clear Goals Set Pharmaceutical Advisory Boards Up for Success

By Yanis Saradjian, Director of Consulting The pharmaceutical industry has always turned to experts and key opinion leaders to shape and inform company policy.  Despite increasing rules on how companies are allowed to interact with physicians,...
 

10.1.2013

The Headaches Behind Warning Labels: Tylenol Put Patients First, Brand Second

By Jennifer Harrell, Research Analyst “A flat prediction I’ll make,” claimed esteemed advertising guru Jerry Della Femina in a New York Times article written in October 1982, just days after arsenic-laced Tylenol fatally poisoned seven Chicagoans,...